nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—ADK—Purine salvage—APRT—nephrolithiasis	0.0617	0.141	CbGpPWpGaD
Ribavirin—NT5C2—Purine metabolism—APRT—nephrolithiasis	0.0387	0.0884	CbGpPWpGaD
Ribavirin—IMPDH1—Purine metabolism—APRT—nephrolithiasis	0.0315	0.0721	CbGpPWpGaD
Ribavirin—ADK—Purine metabolism—APRT—nephrolithiasis	0.0293	0.067	CbGpPWpGaD
Ribavirin—Dry cough—Hydrochlorothiazide—nephrolithiasis	0.0282	0.0721	CcSEcCtD
Ribavirin—NT5C2—Nucleotide metabolism—APRT—nephrolithiasis	0.0194	0.0444	CbGpPWpGaD
Ribavirin—ENPP1—renal system—nephrolithiasis	0.0173	0.11	CbGeAlD
Ribavirin—ENPP1—kidney—nephrolithiasis	0.0167	0.106	CbGeAlD
Ribavirin—IMPDH1—Nucleotide metabolism—APRT—nephrolithiasis	0.0158	0.0362	CbGpPWpGaD
Ribavirin—ADK—Nucleotide metabolism—APRT—nephrolithiasis	0.0147	0.0337	CbGpPWpGaD
Ribavirin—Adenosine monophosphate—APRT—nephrolithiasis	0.0146	1	CrCbGaD
Ribavirin—Cardiac murmur—Hydrochlorothiazide—nephrolithiasis	0.0141	0.036	CcSEcCtD
Ribavirin—NT5C2—nephron tubule—nephrolithiasis	0.0139	0.0884	CbGeAlD
Ribavirin—ENPP1—Endochondral Ossification—PTH—nephrolithiasis	0.0134	0.0307	CbGpPWpGaD
Ribavirin—NT5C2—renal system—nephrolithiasis	0.0126	0.0804	CbGeAlD
Ribavirin—NT5C2—kidney—nephrolithiasis	0.0122	0.0777	CbGeAlD
Ribavirin—NT5C2—cortex of kidney—nephrolithiasis	0.0119	0.0757	CbGeAlD
Ribavirin—IMPDH1—renal system—nephrolithiasis	0.0102	0.0652	CbGeAlD
Ribavirin—IMPDH1—kidney—nephrolithiasis	0.00989	0.0631	CbGeAlD
Ribavirin—ADK—nephron tubule—nephrolithiasis	0.00887	0.0566	CbGeAlD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00872	0.0199	CbGpPWpGaD
Ribavirin—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.00831	0.0212	CcSEcCtD
Ribavirin—ADK—renal system—nephrolithiasis	0.00807	0.0514	CbGeAlD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00798	0.0182	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00798	0.0182	CbGpPWpGaD
Ribavirin—ADK—kidney—nephrolithiasis	0.0078	0.0497	CbGeAlD
Ribavirin—Sexual dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00779	0.0199	CcSEcCtD
Ribavirin—ADK—cortex of kidney—nephrolithiasis	0.0076	0.0484	CbGeAlD
Ribavirin—Toothache—Hydrochlorothiazide—nephrolithiasis	0.00718	0.0183	CcSEcCtD
Ribavirin—SLC29A1—renal system—nephrolithiasis	0.00687	0.0438	CbGeAlD
Ribavirin—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0068	0.0174	CcSEcCtD
Ribavirin—ENPP1—Endochondral Ossification—SPP1—nephrolithiasis	0.00674	0.0154	CbGpPWpGaD
Ribavirin—SLC29A1—kidney—nephrolithiasis	0.00664	0.0423	CbGeAlD
Ribavirin—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.00653	0.0167	CcSEcCtD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0065	0.0149	CbGpPWpGaD
Ribavirin—SLC29A1—cortex of kidney—nephrolithiasis	0.00647	0.0412	CbGeAlD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00605	0.0138	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00605	0.0138	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00595	0.0136	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00595	0.0136	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00562	0.0129	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00562	0.0129	CbGpPWpGaD
Ribavirin—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00556	0.0142	CcSEcCtD
Ribavirin—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00531	0.0136	CcSEcCtD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00501	0.0115	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00497	0.0114	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00497	0.0114	CbGpPWpGaD
Ribavirin—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00494	0.0126	CcSEcCtD
Ribavirin—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.012	CcSEcCtD
Ribavirin—Gout—Hydrochlorothiazide—nephrolithiasis	0.00468	0.012	CcSEcCtD
Ribavirin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00456	0.0117	CcSEcCtD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00451	0.0103	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00451	0.0103	CbGpPWpGaD
Ribavirin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00447	0.0114	CcSEcCtD
Ribavirin—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00445	0.0114	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00443	0.0101	CbGpPWpGaD
Ribavirin—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00442	0.0113	CcSEcCtD
Ribavirin—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00424	0.0108	CcSEcCtD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00419	0.00958	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00419	0.00958	CbGpPWpGaD
Ribavirin—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0041	0.0105	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00405	0.00927	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00405	0.00927	CbGpPWpGaD
Ribavirin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00395	0.0101	CcSEcCtD
Ribavirin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00993	CcSEcCtD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00374	0.00854	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00371	0.00848	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00371	0.00848	CbGpPWpGaD
Ribavirin—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00366	0.00936	CcSEcCtD
Ribavirin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00931	CcSEcCtD
Ribavirin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00923	CcSEcCtD
Ribavirin—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00358	0.00914	CcSEcCtD
Ribavirin—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00897	CcSEcCtD
Ribavirin—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00889	CcSEcCtD
Ribavirin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00874	CcSEcCtD
Ribavirin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00862	CcSEcCtD
Ribavirin—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00334	0.00855	CcSEcCtD
Ribavirin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00851	CcSEcCtD
Ribavirin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00851	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0033	0.00756	CbGpPWpGaD
Ribavirin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00329	0.00841	CcSEcCtD
Ribavirin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00834	CcSEcCtD
Ribavirin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00317	0.0081	CcSEcCtD
Ribavirin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00317	0.0081	CcSEcCtD
Ribavirin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00804	CcSEcCtD
Ribavirin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00797	CcSEcCtD
Ribavirin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00797	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00307	0.00703	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00307	0.00703	CbGpPWpGaD
Ribavirin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00782	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00302	0.00691	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00302	0.00691	CbGpPWpGaD
Ribavirin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.003	0.00767	CcSEcCtD
Ribavirin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00298	0.00762	CcSEcCtD
Ribavirin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00291	0.00743	CcSEcCtD
Ribavirin—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0029	0.0074	CcSEcCtD
Ribavirin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00732	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00286	0.00653	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00286	0.00653	CbGpPWpGaD
Ribavirin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00285	0.0073	CcSEcCtD
Ribavirin—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00715	CcSEcCtD
Ribavirin—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00276	0.00705	CcSEcCtD
Ribavirin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00274	0.007	CcSEcCtD
Ribavirin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00269	0.00686	CcSEcCtD
Ribavirin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00682	CcSEcCtD
Ribavirin—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00256	0.00655	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00651	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00255	0.00582	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00255	0.00582	CbGpPWpGaD
Ribavirin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00647	CcSEcCtD
Ribavirin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00645	CcSEcCtD
Ribavirin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00639	CcSEcCtD
Ribavirin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00637	CcSEcCtD
Ribavirin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00632	CcSEcCtD
Ribavirin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00628	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00619	CcSEcCtD
Ribavirin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00615	CcSEcCtD
Ribavirin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0024	0.00614	CcSEcCtD
Ribavirin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00612	CcSEcCtD
Ribavirin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00612	CcSEcCtD
Ribavirin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00609	CcSEcCtD
Ribavirin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00607	CcSEcCtD
Ribavirin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00607	CcSEcCtD
Ribavirin—NT5C2—Metabolism—GRHPR—nephrolithiasis	0.00233	0.00533	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—GRHPR—nephrolithiasis	0.00233	0.00533	CbGpPWpGaD
Ribavirin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00589	CcSEcCtD
Ribavirin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00586	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00229	0.00524	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00229	0.00524	CbGpPWpGaD
Ribavirin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00571	CcSEcCtD
Ribavirin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00562	CcSEcCtD
Ribavirin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00219	0.0056	CcSEcCtD
Ribavirin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00558	CcSEcCtD
Ribavirin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00556	CcSEcCtD
Ribavirin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00216	0.00552	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00213	0.00487	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00213	0.00487	CbGpPWpGaD
Ribavirin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0054	CcSEcCtD
Ribavirin—ENPP1—Disease—SLC26A1—nephrolithiasis	0.00211	0.00482	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—AGXT—nephrolithiasis	0.00208	0.00475	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AGXT—nephrolithiasis	0.00208	0.00475	CbGpPWpGaD
Ribavirin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00207	0.0053	CcSEcCtD
Ribavirin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00204	0.00523	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00204	0.00465	CbGpPWpGaD
Ribavirin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00204	0.0052	CcSEcCtD
Ribavirin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00501	CcSEcCtD
Ribavirin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00495	CcSEcCtD
Ribavirin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00191	0.00488	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—GRHPR—nephrolithiasis	0.0019	0.00434	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.0019	0.00434	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.0019	0.00434	CbGpPWpGaD
Ribavirin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00188	0.00481	CcSEcCtD
Ribavirin—ENPP1—Disease—ATP6V0A4—nephrolithiasis	0.00188	0.0043	CbGpPWpGaD
Ribavirin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00479	CcSEcCtD
Ribavirin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00478	CcSEcCtD
Ribavirin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00474	CcSEcCtD
Ribavirin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00185	0.00472	CcSEcCtD
Ribavirin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00469	CcSEcCtD
Ribavirin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0018	0.0046	CcSEcCtD
Ribavirin—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00179	0.00457	CcSEcCtD
Ribavirin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00177	0.00453	CcSEcCtD
Ribavirin—ENPP1—Metabolism—APRT—nephrolithiasis	0.00177	0.00404	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—APRT—nephrolithiasis	0.00177	0.00404	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SLC26A1—nephrolithiasis	0.00177	0.00404	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SLC26A1—nephrolithiasis	0.00177	0.00404	CbGpPWpGaD
Ribavirin—ADK—Metabolism—GRHPR—nephrolithiasis	0.00177	0.00404	CbGpPWpGaD
Ribavirin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00176	0.00451	CcSEcCtD
Ribavirin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00175	0.00448	CcSEcCtD
Ribavirin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00174	0.00446	CcSEcCtD
Ribavirin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00172	0.0044	CcSEcCtD
Ribavirin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00438	CcSEcCtD
Ribavirin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00438	CcSEcCtD
Ribavirin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00171	0.00437	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—AGXT—nephrolithiasis	0.00169	0.00387	CbGpPWpGaD
Ribavirin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00431	CcSEcCtD
Ribavirin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00168	0.00429	CcSEcCtD
Ribavirin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00426	CcSEcCtD
Ribavirin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00415	CcSEcCtD
Ribavirin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00415	CcSEcCtD
Ribavirin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00163	0.00415	CcSEcCtD
Ribavirin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00162	0.00414	CcSEcCtD
Ribavirin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00161	0.0041	CcSEcCtD
Ribavirin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00406	CcSEcCtD
Ribavirin—ADK—Metabolism—AGXT—nephrolithiasis	0.00157	0.0036	CbGpPWpGaD
Ribavirin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00157	0.00401	CcSEcCtD
Ribavirin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00398	CcSEcCtD
Ribavirin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00398	CcSEcCtD
Ribavirin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00153	0.00392	CcSEcCtD
Ribavirin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00153	0.0039	CcSEcCtD
Ribavirin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00152	0.00389	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00152	0.00347	CbGpPWpGaD
Ribavirin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00151	0.00385	CcSEcCtD
Ribavirin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00149	0.0038	CcSEcCtD
Ribavirin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00146	0.00372	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—APRT—nephrolithiasis	0.00144	0.00329	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SLC26A1—nephrolithiasis	0.00144	0.00329	CbGpPWpGaD
Ribavirin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00142	0.00363	CcSEcCtD
Ribavirin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0036	CcSEcCtD
Ribavirin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0014	0.00358	CcSEcCtD
Ribavirin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00355	CcSEcCtD
Ribavirin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00139	0.00354	CcSEcCtD
Ribavirin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00137	0.0035	CcSEcCtD
Ribavirin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00135	0.00346	CcSEcCtD
Ribavirin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00134	0.00343	CcSEcCtD
Ribavirin—ADK—Metabolism—APRT—nephrolithiasis	0.00134	0.00306	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SLC26A1—nephrolithiasis	0.00134	0.00306	CbGpPWpGaD
Ribavirin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0034	CcSEcCtD
Ribavirin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00133	0.0034	CcSEcCtD
Ribavirin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00128	0.00328	CcSEcCtD
Ribavirin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00127	0.00326	CcSEcCtD
Ribavirin—ENPP1—Metabolism—AQP1—nephrolithiasis	0.00126	0.00288	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—AQP1—nephrolithiasis	0.00126	0.00288	CbGpPWpGaD
Ribavirin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00124	0.00316	CcSEcCtD
Ribavirin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00315	CcSEcCtD
Ribavirin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00315	CcSEcCtD
Ribavirin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00115	0.00293	CcSEcCtD
Ribavirin—ENPP1—Metabolism—CHRM3—nephrolithiasis	0.00114	0.0026	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CHRM3—nephrolithiasis	0.00114	0.0026	CbGpPWpGaD
Ribavirin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00112	0.00286	CcSEcCtD
Ribavirin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0011	0.00282	CcSEcCtD
Ribavirin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00107	0.00272	CcSEcCtD
Ribavirin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00263	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—AQP1—nephrolithiasis	0.00103	0.00234	CbGpPWpGaD
Ribavirin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000991	0.00253	CcSEcCtD
Ribavirin—Rash—Hydrochlorothiazide—nephrolithiasis	0.000982	0.00251	CcSEcCtD
Ribavirin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000981	0.00251	CcSEcCtD
Ribavirin—Headache—Hydrochlorothiazide—nephrolithiasis	0.000976	0.00249	CcSEcCtD
Ribavirin—ADK—Metabolism—AQP1—nephrolithiasis	0.000953	0.00218	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CHRM3—nephrolithiasis	0.000927	0.00212	CbGpPWpGaD
Ribavirin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000925	0.00237	CcSEcCtD
Ribavirin—ADK—Metabolism—CHRM3—nephrolithiasis	0.000862	0.00197	CbGpPWpGaD
